1. Home
  2. BLCO vs CRVL Comparison

BLCO vs CRVL Comparison

Compare BLCO & CRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • CRVL
  • Stock Information
  • Founded
  • BLCO 1853
  • CRVL 1987
  • Country
  • BLCO Canada
  • CRVL United States
  • Employees
  • BLCO N/A
  • CRVL N/A
  • Industry
  • BLCO Ophthalmic Goods
  • CRVL Specialty Insurers
  • Sector
  • BLCO Health Care
  • CRVL Finance
  • Exchange
  • BLCO Nasdaq
  • CRVL Nasdaq
  • Market Cap
  • BLCO 6.3B
  • CRVL 5.6B
  • IPO Year
  • BLCO 2022
  • CRVL 1991
  • Fundamental
  • Price
  • BLCO $17.17
  • CRVL $110.39
  • Analyst Decision
  • BLCO Buy
  • CRVL
  • Analyst Count
  • BLCO 12
  • CRVL 0
  • Target Price
  • BLCO $20.73
  • CRVL N/A
  • AVG Volume (30 Days)
  • BLCO 396.1K
  • CRVL 134.2K
  • Earning Date
  • BLCO 02-19-2025
  • CRVL 01-31-2025
  • Dividend Yield
  • BLCO N/A
  • CRVL N/A
  • EPS Growth
  • BLCO N/A
  • CRVL 9.77
  • EPS
  • BLCO N/A
  • CRVL 1.57
  • Revenue
  • BLCO $4,684,000,000.00
  • CRVL $845,638,000.00
  • Revenue This Year
  • BLCO $17.32
  • CRVL N/A
  • Revenue Next Year
  • BLCO $5.98
  • CRVL N/A
  • P/E Ratio
  • BLCO N/A
  • CRVL $69.33
  • Revenue Growth
  • BLCO 18.01
  • CRVL 12.66
  • 52 Week Low
  • BLCO $13.16
  • CRVL $74.63
  • 52 Week High
  • BLCO $21.69
  • CRVL $127.24
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 35.11
  • CRVL 47.02
  • Support Level
  • BLCO $17.00
  • CRVL $108.70
  • Resistance Level
  • BLCO $17.57
  • CRVL $112.10
  • Average True Range (ATR)
  • BLCO 0.45
  • CRVL 2.73
  • MACD
  • BLCO -0.00
  • CRVL 0.07
  • Stochastic Oscillator
  • BLCO 22.80
  • CRVL 65.05

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

Share on Social Networks: